Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles

Xiangyi Li(Shanghai Ocean University), Lu Xie(Guangxi Medical University), Yingjie Xu(Tongren Hospital), Hui Cui(Shanghai Center For Bioinformation Technology), Disong Wang(Shanghai Center For Bioinformation Technology), Lanming Chen(Shanghai Ocean University), Wěi Li(First Affiliated Hospital of Xi'an Jiaotong University), Tao Huang(Icahn School of Medicine at Mount Sinai), Baofeng Lian(Unimed Medical Institute), Guangrong Qin(Institute for Systems Biology)
Artificial Intelligence in Medicine
June 4, 2017
10.1016/j.artmed.2017.05.008
Cited by 128

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|977
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
|Cell|2020|640
Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion
|Nature Neuroscience|2018|610